Aptar Pharma, drug delivery systems, services, and active packaging solutions provider, has announced its Platinum Sponsorship of the CPhI Festival of Pharma, to be held online from 5 to 16 October 2020. A long-time strategic partner and supporter of CPhI events globally, Aptar Pharma will unveil a new, state-of-the-art interactive booth at this virtual event that captures the essence of an in-person experience during these unprecedented times.
Headquartered in Crystal Lake, Illinois, Aptar Pharma is part of AptarGroup, a global leader in designing and manufacturing a broad range of drug delivery, consumer product dispensing, and active packaging solutions. Aptar uses insights, design, engineering, and science to create dosing, dispensing, and protective packaging technologies for the world’s leading brands, in turn making a meaningful difference in the lives, looks, health, and homes of millions of people around the world. Aptar’s innovative solutions and services serve various end markets, including pharmaceutical, beauty, personal care, home, food, and beverage. The company has 14,000 dedicated employees in 20 countries, including India.
Enhancing the virtual visitor experience
Part of their company showcase, which will be available to visitors of the event for 12 months, Aptar Pharma’s virtual booth will bring to life why it is the go-to drug delivery partner, unlocking value for customers throughout their product development journey.
According to Aptar, rich in content, featuring multi-media videos, brochures, scientific publications, and other experiences, Aptar Pharma’s life-like booth will allow visitors to explore, discover and interact with their broad range of complete product and service solutions, further enhancing the virtual experience.
Carolyn Penot, director of Operational Marketing at Aptar Pharma, commented, “As a longstanding partner of CPhI, we wanted to show our full support for their new Festival of Pharma digital event and are proud to be a platinum sponsor. Aptar Pharma’s virtual experience gives us the opportunity to continue to support our worldwide customers, in the absence of in-person events this year, in a new and engaging way.”
Transforming ideas into opportunities
Aptar Pharma will showcase in 3D its latest range of innovations, including:
- PureHale – a portable and ready-to-use drug delivery solution designed for upper respiratory care
- Connected Add-On Device for metered-dose inhalers (MDIs)
- Unidose Trainer Device – a pioneering patient onboarding device from Noble, an Aptar Pharma company, was used for the first and only US FDA-approved nasal rescue treatment for seizure activity based on Aptar Pharma’s UDS device.
An essential industry partner during Covid-19
Aptar Pharma has been an essential partner to the industry during the Covid-19 pandemic, ensuring the supply of its portfolio of drug delivery solutions that improve and save lives, which is especially important for customers and patients pandemic continues to dominate the healthcare environment.
Discover how Aptar Pharma services can accelerate and derisk drug development and how its proven solutions enable the rapid deployment of Covid-related vaccines and treatments for customers.
Recognizing innovation excellence
Aptar Pharma is proud to be a finalist for four Digital CPhI Pharma Awards at this year’s event:
- Excellence in Pharma: Drug Delivery Devices – PureHale Portable Upper Respiratory Device
- Excellence in Pharma: Packaging – Activ-Blister by Aptar CSP Technologies
- Excellence in Pharma: Packaging – Noble’s Unidose Nasal Training Kit for Nayzilam
- Excellence in Pharma: Innovation in Response to COVID-19 – ActivShield by Aptar CSP Technologies.
The winners of the Digital CPhI Pharma Awards will be announced during a live online ceremony on 13 October at 16:00 (CET).
Sharing expertise with a global audience
As part of the CPhI Festival of Pharma conference program, two Aptar Pharma experts will share critical industry insights and expertise during the two-week event:
On October 6 at 11:00 CET, Aptar Pharma will sponsor “The Future of Drug Delivery” Keynote Speaker webinar on patient-focused drug design, which will be introduced by Tim McLeroy, executive director of Marketing and Patient Services at Noble, an Aptar Pharma company. Tim’s presentation will highlight the importance of remote patient training, onboarding, and monitoring – which has increased during Covid-19 – for improving patient adherence and outcomes.
On October 8 at 15:30 CET, Sai Shankar, vice-president Global Digital Healthcare Systems at Aptar Pharma, will participate in a live panel discussion entitled “Trends in Pharma Packaging, Administration & Drug Delivery Devices”. As part of his panel discussion, Sai will present on the “Increasing Importance of Connected Devices and Digitalization in Post Pandemic R&D”.
CPhI Festival of Pharma visitors can register to attend these critical presentations via the event website.
Enlarging the access to global pharma expertise
At the virtual format at CPhI Festival of Pharma, Aptar Pharma will be providing expanded access to its experts from around the world and across all delivery routes via online meeting slots, which provide an excellent meeting or networking opportunity. Both new and existing customers can book their meetings by visiting the Aptar Pharma company showcase.
Gael Touya, president of Aptar Pharma, commented, “CPhI plays a pivotal role in the global pharma industry, providing the perfect platforms to meet, network and ultimately do business together. This year, we are happy to support CPhI with its Festival of Pharma and are proud to have created a virtual platform that will deliver the highest quality visitor experience and demonstrate to the industry what makes Aptar Pharma the go-to drug delivery expert.”
The CPhI Festival of Pharma event promises to bring the global pharma industry together and expect to welcome over 20,000 attendees and over 700 exhibitors from around the world, offering best-in-class networking, learning, and sourcing opportunities – from the comfort of the home office.
Click here to register.